Liu et al. in 1998 reported PSMA itself internalizes efficiently through clathrin-coated vesicles [36], and in metastatic prostate cancer cells, receptor expression is 100–1000 times higher than in normal prostate tissue [37]. The gene discussed is FOLH1; the disease is prostate cancer.